Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors.
Klotz
Ulrich
U
D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D018570:Risk Assessment; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib